Cargando…

Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET

INTRODUCTION: Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well‐oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE...

Descripción completa

Detalles Bibliográficos
Autores principales: Henjum, Helge, Dahle, Tordis Johnsen, Mairani, Andrea, Pilskog, Sara, Stokkevåg, Camilla, Boer, Camilla Grindeland, Redalen, Kathrine Røe, Minn, Heikki, Malinen, Eirik, Ytre‐Hauge, Kristian Smeland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476997/
https://www.ncbi.nlm.nih.gov/pubmed/37161820
http://dx.doi.org/10.1002/acm2.14014
_version_ 1785101053597843456
author Henjum, Helge
Dahle, Tordis Johnsen
Mairani, Andrea
Pilskog, Sara
Stokkevåg, Camilla
Boer, Camilla Grindeland
Redalen, Kathrine Røe
Minn, Heikki
Malinen, Eirik
Ytre‐Hauge, Kristian Smeland
author_facet Henjum, Helge
Dahle, Tordis Johnsen
Mairani, Andrea
Pilskog, Sara
Stokkevåg, Camilla
Boer, Camilla Grindeland
Redalen, Kathrine Røe
Minn, Heikki
Malinen, Eirik
Ytre‐Hauge, Kristian Smeland
author_sort Henjum, Helge
collection PubMed
description INTRODUCTION: Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well‐oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE) could therefore be used to adapt to patient‐specific radioresistance governed by intrinsic radiosensitivity and hypoxia. METHODS: A combined RBE and OER weighted dose (ROWD) calculation method was implemented in a FLUKA Monte Carlo (MC) based treatment planning tool. The method is based on the linear quadratic model, with α and β parameters as a function of the OER, and therefore a function of the linear energy transfer (LET) and partial oxygen pressure (pO(2)). Proton therapy plans for two head and neck cancer (HNC) patients were optimized with pO(2) estimated from [(18)F]‐EF5 positron emission tomography (PET) images. For the ROWD calculations, an RBE of 1.1 (RBE(1.1,OER)) and two variable RBE models, Rørvik (ROR) and McNamara (MCN), were used, alongside a reference plan without incorporation of OER (RBE(1.1)). RESULTS: For the HNC patients, treatment plans in line with the prescription dose and with acceptable target ROWD could be generated with the established tool. The physical dose was the main factor modulated in the ROWD. The impact of incorporating OER during optimization of HNC patients was demonstrated by the substantial difference found between ROWD and physical dose in the hypoxic tumor region. The largest physical dose differences between the ROWD optimized plans and the reference plan was 12.2 Gy. CONCLUSION: The FLUKA MC based tool was able to optimize proton treatment plans taking the tumor pO(2) distribution from hypoxia PET images into account. Independent of RBE‐model, both elevated LET and physical dose were found in the hypoxic regions, which shows the potential to increase the tumor control compared to a conventional optimization approach.
format Online
Article
Text
id pubmed-10476997
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104769972023-09-05 Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET Henjum, Helge Dahle, Tordis Johnsen Mairani, Andrea Pilskog, Sara Stokkevåg, Camilla Boer, Camilla Grindeland Redalen, Kathrine Røe Minn, Heikki Malinen, Eirik Ytre‐Hauge, Kristian Smeland J Appl Clin Med Phys Radiation Oncology Physics INTRODUCTION: Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well‐oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE) could therefore be used to adapt to patient‐specific radioresistance governed by intrinsic radiosensitivity and hypoxia. METHODS: A combined RBE and OER weighted dose (ROWD) calculation method was implemented in a FLUKA Monte Carlo (MC) based treatment planning tool. The method is based on the linear quadratic model, with α and β parameters as a function of the OER, and therefore a function of the linear energy transfer (LET) and partial oxygen pressure (pO(2)). Proton therapy plans for two head and neck cancer (HNC) patients were optimized with pO(2) estimated from [(18)F]‐EF5 positron emission tomography (PET) images. For the ROWD calculations, an RBE of 1.1 (RBE(1.1,OER)) and two variable RBE models, Rørvik (ROR) and McNamara (MCN), were used, alongside a reference plan without incorporation of OER (RBE(1.1)). RESULTS: For the HNC patients, treatment plans in line with the prescription dose and with acceptable target ROWD could be generated with the established tool. The physical dose was the main factor modulated in the ROWD. The impact of incorporating OER during optimization of HNC patients was demonstrated by the substantial difference found between ROWD and physical dose in the hypoxic tumor region. The largest physical dose differences between the ROWD optimized plans and the reference plan was 12.2 Gy. CONCLUSION: The FLUKA MC based tool was able to optimize proton treatment plans taking the tumor pO(2) distribution from hypoxia PET images into account. Independent of RBE‐model, both elevated LET and physical dose were found in the hypoxic regions, which shows the potential to increase the tumor control compared to a conventional optimization approach. John Wiley and Sons Inc. 2023-05-10 /pmc/articles/PMC10476997/ /pubmed/37161820 http://dx.doi.org/10.1002/acm2.14014 Text en © 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Henjum, Helge
Dahle, Tordis Johnsen
Mairani, Andrea
Pilskog, Sara
Stokkevåg, Camilla
Boer, Camilla Grindeland
Redalen, Kathrine Røe
Minn, Heikki
Malinen, Eirik
Ytre‐Hauge, Kristian Smeland
Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title_full Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title_fullStr Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title_full_unstemmed Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title_short Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
title_sort combined rbe and oer optimization in proton therapy with fluka based on ef5‐pet
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476997/
https://www.ncbi.nlm.nih.gov/pubmed/37161820
http://dx.doi.org/10.1002/acm2.14014
work_keys_str_mv AT henjumhelge combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT dahletordisjohnsen combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT mairaniandrea combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT pilskogsara combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT stokkevagcamilla combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT boercamillagrindeland combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT redalenkathrinerøe combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT minnheikki combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT malineneirik combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet
AT ytrehaugekristiansmeland combinedrbeandoeroptimizationinprotontherapywithflukabasedonef5pet